Clinical Trial Update: Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Huaier Granule as adjuvant treatment for high-risk early-stage triple-negative breast cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Huaier Granule

Snippet

Sponsor: Fudan University | Conditions: Carcinoma Breast, Triple-negative Breast Cancer | Phase 4 | Status: RECRUITING